[144] Mastercard Incorporated SEC Filing

Rhea-AI Filing Summary

Mastercard (MA) Form 144 notice reports a proposed sale of 3,855 common shares on the NYSE through Morgan Stanley Smith Barney. The filing shows an aggregate market value of $2,281,851.60 and an approximate sale date of 08/22/2025. The securities were acquired on 08/22/2025 by exercise of stock options from the issuer, with payment in cash. The filer indicates no securities sold in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Insider exercised options and filed to sell 3,855 shares valued at $2.28M; amount appears immaterial to Mastercard's market cap.

The filing documents an option exercise and immediate proposed sale of 3,855 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $2,281,851.60 and a listed sale date of 08/22/2025. No prior sales in the past three months are reported. From an investor-impact perspective, the disclosed size is small relative to Mastercard's public float, suggesting limited market impact. The transaction is routine: exercise of options and cash payment, with no additional compensation arrangements disclosed.

Corporate Governance Expert

TL;DR: Filing reflects a routine insider liquidity event with required certification about absence of material nonpublic information.

The notice includes the mandatory representation that the seller does not know material adverse undisclosed information and references Rule 10b5-1 procedures if applicable, although no plan adoption date is provided. The transaction type and broker are specified, but the filing omits identifying filer details in the provided extract. This is a standard compliance disclosure rather than a governance red flag based on the information shown.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3855	2281851.60	897274172	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Exercise of Stock Options	Issuer			3855	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Mastercard's (MA) Form 144 disclose?

The filing discloses a proposed sale of 3,855 common shares on 08/22/2025 via Morgan Stanley Smith Barney on the NYSE, with aggregate value $2,281,851.60.

How were the Mastercard shares acquired for this Form 144 sale?

The shares were acquired on 08/22/2025 by exercise of stock options issued by the issuer, with payment made in cash.

Has the person sold other Mastercard shares in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are listed for the proposed sale?

Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, address provided; Exchange: NYSE.

Does the filing indicate possession of any undisclosed material information?

The person represents they do not know any material adverse nonpublic information; no plan adoption date for Rule 10b5-1 is provided in the excerpt.